Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.56 NOK | -0.81% | +13.83% | -93.03% |
Jun. 11 | Ultimovacs Asa Provides Update from Phase I Study in Malignant Melanoma | CI |
May. 07 | Transcript : Ultimovacs ASA, Q1 2024 Earnings Call, May 07, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ULTIMOVACS ASA | Other Biotechnology & Medical Research | -0.81% | +13.83% | -93.03% | -89.07% | -72.56% | 27.53M |
- Stock Market
- Equities
- ULTI Stock
- Charts Ultimovacs ASA
- Relative Strength Chart